Search research articles
Contact Us
Filters
Showing results (1-10 of 76) with videos related to
Page
of 8
Sort By:
Handbook of Experimental Pharmacology
|
January 29, 2018
Bioanalytical Methods for New Psychoactive Substances
Lea Wagmann, Hans H Maurer
Archives of Toxicology
|
August 20, 2021
Altered metabolic pathways elucidated via untargeted in vivo toxicometabolomics in rat urine and plasma samples collected after controlled application of a human equivalent amphetamine dose
Selina Hemmer, Lea Wagmann, Markus R Meyer
Drug Testing and Analysis
|
December 11, 2024
Studies on the Stability and Microbial Biotransformation of Five Deschloroketamine Derivatives as Prerequisite for Wastewater-Based Epidemiology Screening
Fabian Frankenfeld, Lea Wagmann, Markus R Meyer
Drug Testing and Analysis
|
August 23, 2022
Analytical toxicology of yew constituents in human blood and urine by liquid chromatography-high-resolution tandem mass spectrometry
Cathy M Jacobs, Lea Wagmann, Markus R Meyer
Archives of Toxicology
|
August 8, 2018
Inhibition and stimulation of the human breast cancer resistance protein as in vitro predictor of drug-drug interactions of drugs of abuse
Lea Wagmann, Hans H Maurer, Markus R Meyer
Drug Testing and Analysis
|
September 7, 2021
Toxic plants-Detection of colchicine in a fast systematic clinical toxicology screening using liquid chromatography-mass spectrometry
Aline C Vollmer, Lea Wagmann, Markus R Meyer
Analytical and Bioanalytical Chemistry
|
January 31, 2021
Development, validation, and application of a quantitative volumetric absorptive microsampling-based method in finger prick blood by means of LC-HRMS/MS applicable for adherence monitoring of antipsychotics
Cathy M Jacobs, Lea Wagmann, Markus R Meyer
Therapeutic Drug Monitoring
|
February 17, 2022
New Psychoactive Substances: Which Biological Matrix Is the Best for Clinical Toxicology Screening?
Lea Wagmann, Cathy M Jacobs, Markus R Meyer
Journal of Analytical Toxicology
|
June 8, 2021
Can the Intake of a Synthetic Tryptamine be Detected Only by Blood Plasma Analysis? A Clinical Toxicology Case Involving 4-HO-MET
Lea Wagmann, Sascha K Manier, Markus R Meyer
Analytical and Bioanalytical Chemistry
|
April 1, 2021
Recent trends in drugs of abuse metabolism studies for mass spectrometry-based analytical screening procedures
Lea Wagmann, Tanja M Gampfer, Markus R Meyer
Page
of 8
Search research articles
Search
Showing results (1-10 of 76) with videos related to
Sort By:
Page
of 8
Handbook of Experimental Pharmacology
|
January 29, 2018
Bioanalytical Methods for New Psychoactive Substances
Lea Wagmann, Hans H Maurer
Archives of Toxicology
|
August 20, 2021
Altered metabolic pathways elucidated via untargeted in vivo toxicometabolomics in rat urine and plasma samples collected after controlled application of a human equivalent amphetamine dose
Selina Hemmer, Lea Wagmann, Markus R Meyer
Drug Testing and Analysis
|
December 11, 2024
Studies on the Stability and Microbial Biotransformation of Five Deschloroketamine Derivatives as Prerequisite for Wastewater-Based Epidemiology Screening
Fabian Frankenfeld, Lea Wagmann, Markus R Meyer
Drug Testing and Analysis
|
August 23, 2022
Analytical toxicology of yew constituents in human blood and urine by liquid chromatography-high-resolution tandem mass spectrometry
Cathy M Jacobs, Lea Wagmann, Markus R Meyer
Archives of Toxicology
|
August 8, 2018
Inhibition and stimulation of the human breast cancer resistance protein as in vitro predictor of drug-drug interactions of drugs of abuse
Lea Wagmann, Hans H Maurer, Markus R Meyer
Drug Testing and Analysis
|
September 7, 2021
Toxic plants-Detection of colchicine in a fast systematic clinical toxicology screening using liquid chromatography-mass spectrometry
Aline C Vollmer, Lea Wagmann, Markus R Meyer
Analytical and Bioanalytical Chemistry
|
January 31, 2021
Development, validation, and application of a quantitative volumetric absorptive microsampling-based method in finger prick blood by means of LC-HRMS/MS applicable for adherence monitoring of antipsychotics
Cathy M Jacobs, Lea Wagmann, Markus R Meyer
Therapeutic Drug Monitoring
|
February 17, 2022
New Psychoactive Substances: Which Biological Matrix Is the Best for Clinical Toxicology Screening?
Lea Wagmann, Cathy M Jacobs, Markus R Meyer
Journal of Analytical Toxicology
|
June 8, 2021
Can the Intake of a Synthetic Tryptamine be Detected Only by Blood Plasma Analysis? A Clinical Toxicology Case Involving 4-HO-MET
Lea Wagmann, Sascha K Manier, Markus R Meyer
Analytical and Bioanalytical Chemistry
|
April 1, 2021
Recent trends in drugs of abuse metabolism studies for mass spectrometry-based analytical screening procedures
Lea Wagmann, Tanja M Gampfer, Markus R Meyer
Page
of 8